Clinical Trial Update: Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Yiqi Wenjing prescriptions for preventive efficacy against oxaliplatin-induced peripheral neuropathy in colorectal cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer

Drugs mentioned

• Yiqi Wenjing prescriptions

Snippet

Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd. | Conditions: Chemotherapy-induced Peripheral Neuropathy, Colorectal Cancer | Phase 3 | Status: UNKNOWN